Grifols: stock rises on broker upgrade

(CercleFinance.com) - The Grifols stock is up 3% in Madrid, boosted by comments from Credit Suisse, which has upgraded its rating on the Spanish healthcare group's stock from "neutral" to "outperform," increasing its corresponding target price from 24 euros to 25 euros.


"We see the recent de-rating -9% YTD relative to plasma peers (flat YTD), and EU specialty pharma peers (-5% YTD) as overdone," the broker said.


Copyright (c) 2021 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.